153 related articles for article (PubMed ID: 18023981)
1. Roles of plasma membrane-associated sialidase NEU3 in human cancers.
Miyagi T; Wada T; Yamaguchi K
Biochim Biophys Acta; 2008 Mar; 1780(3):532-7. PubMed ID: 18023981
[TBL] [Abstract][Full Text] [Related]
2. Plasma membrane-associated sialidase is up-regulated in renal cell carcinoma and promotes interleukin-6-induced apoptosis suppression and cell motility.
Ueno S; Saito S; Wada T; Yamaguchi K; Satoh M; Arai Y; Miyagi T
J Biol Chem; 2006 Mar; 281(12):7756-64. PubMed ID: 16428383
[TBL] [Abstract][Full Text] [Related]
3. Sialidase NEU3 contributes neoplastic potential on colon cancer cells as a key modulator of gangliosides by regulating Wnt signaling.
Takahashi K; Hosono M; Sato I; Hata K; Wada T; Yamaguchi K; Nitta K; Shima H; Miyagi T
Int J Cancer; 2015 Oct; 137(7):1560-73. PubMed ID: 25810027
[TBL] [Abstract][Full Text] [Related]
4. The plasma membrane sialidase NEU3 regulates the malignancy of renal carcinoma cells by controlling β1 integrin internalization and recycling.
Tringali C; Lupo B; Silvestri I; Papini N; Anastasia L; Tettamanti G; Venerando B
J Biol Chem; 2012 Dec; 287(51):42835-45. PubMed ID: 23139422
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression.
Kakugawa Y; Wada T; Yamaguchi K; Yamanami H; Ouchi K; Sato I; Miyagi T
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10718-23. PubMed ID: 12149448
[TBL] [Abstract][Full Text] [Related]
6. Plasma membrane-associated sialidase as a crucial regulator of transmembrane signalling.
Miyagi T; Wada T; Yamaguchi K; Hata K; Shiozaki K
J Biochem; 2008 Sep; 144(3):279-85. PubMed ID: 18632803
[TBL] [Abstract][Full Text] [Related]
7. Sialidase NEU3 and its pathological significance.
Miyagi T; Yamamoto K
Glycoconj J; 2022 Oct; 39(5):677-683. PubMed ID: 35675020
[TBL] [Abstract][Full Text] [Related]
8. Increased sialidase activity in serum of cancer patients: Identification of sialidase and inhibitor activities in human serum.
Hata K; Tochigi T; Sato I; Kawamura S; Shiozaki K; Wada T; Takahashi K; Moriya S; Yamaguchi K; Hosono M; Miyagi T
Cancer Sci; 2015 Apr; 106(4):383-9. PubMed ID: 25652216
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidic acid-mediated activation and translocation to the cell surface of sialidase NEU3, promoting signaling for cell migration.
Shiozaki K; Takahashi K; Hosono M; Yamaguchi K; Hata K; Shiozaki M; Bassi R; Prinetti A; Sonnino S; Nitta K; Miyagi T
FASEB J; 2015 May; 29(5):2099-111. PubMed ID: 25678627
[TBL] [Abstract][Full Text] [Related]
10. Human sialidase as a cancer marker.
Miyagi T; Wada T; Yamaguchi K; Shiozaki K; Sato I; Kakugawa Y; Yamanami H; Fujiya T
Proteomics; 2008 Aug; 8(16):3303-11. PubMed ID: 18651674
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of epidermal growth factor-mediated oncogenic transformation by sialidase NEU3 leading to Src activation.
Yamamoto K; Takahashi K; Shiozaki K; Yamaguchi K; Moriya S; Hosono M; Shima H; Miyagi T
PLoS One; 2015; 10(3):e0120578. PubMed ID: 25803810
[TBL] [Abstract][Full Text] [Related]
12. Plasma membrane-associated sialidase (NEU3) promotes formation of colonic aberrant crypt foci in azoxymethane-treated transgenic mice.
Shiozaki K; Yamaguchi K; Sato I; Miyagi T
Cancer Sci; 2009 Apr; 100(4):588-94. PubMed ID: 19215228
[TBL] [Abstract][Full Text] [Related]
13. A crucial role of plasma membrane-associated sialidase in the survival of human cancer cells.
Wada T; Hata K; Yamaguchi K; Shiozaki K; Koseki K; Moriya S; Miyagi T
Oncogene; 2007 Apr; 26(17):2483-90. PubMed ID: 17334392
[TBL] [Abstract][Full Text] [Related]
14. Reduced susceptibility to colitis-associated colon carcinogenesis in mice lacking plasma membrane-associated sialidase.
Yamaguchi K; Shiozaki K; Moriya S; Koseki K; Wada T; Tateno H; Sato I; Asano M; Iwakura Y; Miyagi T
PLoS One; 2012; 7(7):e41132. PubMed ID: 22815940
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of sialidase and cancer progression.
Miyagi T
Proc Jpn Acad Ser B Phys Biol Sci; 2008; 84(10):407-18. PubMed ID: 19075514
[TBL] [Abstract][Full Text] [Related]
16. Sialidase and malignancy: a minireview.
Miyagi T; Wada T; Yamaguchi K; Hata K
Glycoconj J; 2004; 20(3):189-98. PubMed ID: 15090732
[TBL] [Abstract][Full Text] [Related]
17. Identification of lysosomal sialidase NEU1 and plasma membrane sialidase NEU3 in human erythrocytes.
D'Avila F; Tringali C; Papini N; Anastasia L; Croci G; Massaccesi L; Monti E; Tettamanti G; Venerando B
J Cell Biochem; 2013 Jan; 114(1):204-11. PubMed ID: 22903576
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and biochemical characterization of two novel Neu3 sialidases, neu3a and neu3b, from medaka (Oryzias latipes).
Shiozaki K; Takeshita K; Ikeda M; Ikeda A; Harasaki Y; Komatsu M; Yamada S; Yamaguchi K; Miyagi T
Biochimie; 2013 Feb; 95(2):280-9. PubMed ID: 23032629
[TBL] [Abstract][Full Text] [Related]
19. Biological and Pathological Roles of Ganglioside Sialidases.
Miyagi T; Takahashi K; Yamamoto K; Shiozaki K; Yamaguchi K
Prog Mol Biol Transl Sci; 2018; 156():121-150. PubMed ID: 29747812
[TBL] [Abstract][Full Text] [Related]
20. Membrane sialidase NEU3 is highly expressed in human melanoma cells promoting cell growth with minimal changes in the composition of gangliosides.
Miyata M; Kambe M; Tajima O; Moriya S; Sawaki H; Hotta H; Kondo Y; Narimatsu H; Miyagi T; Furukawa K; Furukawa K
Cancer Sci; 2011 Dec; 102(12):2139-49. PubMed ID: 21895867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
